LeMaitre Vascular (LMAT) vs Tandem Diabetes Care (TNDM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tandem Diabetes Care (TNDM) has outperformed LeMaitre Vascular (LMAT) over the past year, gaining 2.2% versus a loss of 9.5%. Over five years, LMAT leads with a +48.6% price change compared with -87.5% for TNDM. LeMaitre Vascular is the larger company by market cap ($1.82 billion vs $1.09 billion), about 1.7 times the size.
On valuation, LeMaitre Vascular trades at a lower forward P/E (25.1x vs 98.6x for Tandem Diabetes Care). LeMaitre Vascular pays a dividend yielding 1.13%, while Tandem Diabetes Care does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMAT | TNDM |
|---|---|---|
| Share price | $79.64 | $15.68 |
| Market cap | $1.82B | $1.09B |
| 1-day change | +0.42% | -1.04% |
| YTD return | -1.80% | -28.69% |
| 1-year return | -9.54% | +2.18% |
| 5-year return | +48.64% | -87.50% |
| P/E ratio (TTM) | 27.94 | — |
| Forward P/E | 25.05 | 98.61 |
| EPS (TTM) | $2.85 | $-0.91 |
| Dividend yield | 1.13% | 0.00% |
| Annual dividend | $0.90 | $0.00 |
| 52-week high | $118.01 | $29.65 |
| 52-week low | $78.22 | $12.26 |
| Distance from 52-week high | -32.51% | -47.13% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +34.35% | +77.74% |
| Average volume | 330.14K | 2.01M |
| Shares outstanding | 22.87M | 69.58M |
| Employees | 646 | 2,500 |
| Sector | Healthcare | Health Care |
| Industry | Medical Instruments & Supplies | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TNDM has outperformed LMAT by 11.7 percentage points over the past year.
- LeMaitre Vascular offers a meaningfully higher dividend yield (1.13% vs 0.00%).
- The two companies sit in different sectors: LeMaitre Vascular in Healthcare and Tandem Diabetes Care in Health Care.
About LeMaitre Vascular
LMAT stock →LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Healthcare · Medical Instruments & Supplies · 646 employees
About Tandem Diabetes Care
TNDM stock →Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
Health Care · Medical/Dental Instruments · 2,500 employees
LMAT vs TNDM FAQ
Which is bigger, LeMaitre Vascular or Tandem Diabetes Care?
LeMaitre Vascular (LMAT) is larger, with a market capitalization of $1.82B compared with $1.09B for Tandem Diabetes Care (TNDM).
Which stock has performed better over the past year, LMAT or TNDM?
TNDM returned +2.18% over the past 12 months, compared with -9.54% for LMAT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, LeMaitre Vascular or Tandem Diabetes Care?
LeMaitre Vascular pays a dividend yielding 1.13%, while Tandem Diabetes Care does not currently pay a regular dividend.
Are LeMaitre Vascular and Tandem Diabetes Care in the same industry?
No. LeMaitre Vascular is in the Healthcare sector, while Tandem Diabetes Care is in Health Care.